Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Investigating potential fetal exposure to antidepressants

  • Difficult grammar affects music experience

  • Parkinson's disease diagnosis may be preceded by increased risk of injury-causing falls

  • Pills for anxiety, sleep problems not linked to increased dementia risk

  • Online therapy can help those affected by body dysmorphic disorder

  • 'Schizophrenia' does not exist, argues expert

  • Risk of premature death nine-fold among illicit drug users

  • Women are seen more than heard in online news

  • Fixing published research mistakes not easy; fixing the publishing system may be harder

  • Cells that show where things are going

  •